QPharma AB
PolandAll drugs from this manufacturer
-
This medicine is used to reduce an increased number of blood platelets (thrombocytes) in people with essential thrombocythemia. This helps to reduce the risk of circulatory and blood clotting problems.
Dosage form: tablets
Active substance Dosage anagrelide 0.75 mg ATC: L01XX35
-
This medicine is used to reduce an increased number of platelets (thrombocytes) in patients with essential thrombocythemia. This helps to reduce the risk of circulatory and blood clotting problems.
Dosage form: tablets
Active substance Dosage anagrelide 1 mg ATC: L01XX35
-
This medicine is used to reduce an increased number of blood platelets (thrombocytes) in people suffering from essential thrombocythemia. This helps to reduce the risk of circulatory and blood clotting problems.
Dosage form: tablets
Active substance Dosage anagrelide 0.5 mg ATC: L01XX35